Prot #M12-950: An Open-Label Phase 1b Study of the Safety and Tolerability of Veliparib in Combination with Capecitabine and Radiation in Subjects with Locally Advanced Rectal Cancer (LARC)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/24/12 → 7/24/18

Funding

  • Abbott Laboratories (Prot #M12-950)